Immunological studies of mitoxantrone in primary progressive MS
β Scribed by Clara M. Pelfrey; Anne C. Cotleur; Natacha Zamor; Jar-Chi Lee; Robert J. Fox
- Book ID
- 113729815
- Publisher
- Elsevier Science
- Year
- 2006
- Tongue
- English
- Weight
- 162 KB
- Volume
- 175
- Category
- Article
- ISSN
- 0165-5728
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Forty-nine patients with histologically conlirmed primary liver cancer have been entered on phase II trials of mitoxantrone (NovantroneC"~; dihydroxyanthracenedione), at a dose of 14 mg/m 2 every 3 weeks. Among the patients evaluable for toxicity, leukopenia and thrombocytopenia were the most import
## Abstract Lymphocytes from diseaseβfree women and women with primary breast carcinoma were comparable visβaβvis their capacity to inactivate breast tumor cells __in vitro__. Sera from comparable numbers of women in each of these two groups either blocked, potentiated or left unaffected the antiβt